D3 is used. The study by Chailurkit et al. [1] provides data from samples with no previous vitamin D3 supplementation. On the other hand, if future studies derive a biological role for 3-epi-25(OH) D3, it could be hypothesized that it manifests a distinct role to that of 25(OH) D3.
Secondly, previous data have reported that epimers might play a role in disease activity in several diseases, including Alzheimer's disease, type 1 diabetes, and rheumatoid arthritis [2] . Analysis of 10 forms of vitamin D revealed that the 3-epi-25(OH)D3 form is present at significantly higher levels in those suffering from Alzheimer's disease, type 1 diabetes, and rheumatoid arthritis (healthy controls 6.093 ± 6.711 nmol/L; combined disease=22.433±13.535 nmol/L, t(52.5)=−6.411; P<.001). Furthermore, both 3-epi-25(OH)D level and proportion, but not the epimer-free 25(OH)D, showed good diagnostic power for the chronic disease status (AUC=0.880, P<.001). These results warrant further investigation in large-scale studies, along with an expansion to other chronic diseases that have been previously linked to vitamin D.
Finally, we would like to emphasize on the need for similar studies from a wide range of infant samples. While previous data indicated that neonatal and infant vitamin D stores are reliant from maternal ones [3] , routine accurate measurement of epimers could overcome the technical flaws provoked by the presence of a significant percentage of epimers as a fraction of total vitamin D levels.
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